Shares outstanding · 2011–2025
Sinovac Biotech shares outstanding
71.9M0.0% · FY2025
Sinovac Biotech (SVA) reported 71.9M in shares outstanding for fiscal 2025, 0.0% year on year.
| Fiscal year | Shares outstanding | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | 71.9M | 0.0% | Open → |
| FY20242024-12-31 | 71.9M | −27.9% | Open → |
| FY20232023-12-31 | 99.6M | +0.1% | Open → |
| FY20222022-12-31 | 99.5M | 0.0% | Open → |
| FY20212021-12-31 | 99.5M | +0.2% | Open → |
| FY20202020-12-31 | 99.3M | +0.4% | Open → |
| FY20192019-12-31 | 98.9M | +39.0% | Open → |
| FY20182018-12-31 | 71.1M | +24.2% | Open → |
| FY20172017-12-31 | 57.3M | +0.5% | Open → |
| FY20162016-12-31 | 57.0M | +0.2% | Open → |
| FY20152015-12-31 | 56.9M | +2.0% | Open → |
| FY20142014-12-31 | 55.8M | +0.4% | Open → |
| FY20132013-12-31 | 55.6M | +0.9% | Open → |
| FY20122012-12-31 | 55.1M | +0.6% | Open → |
| FY20112011-12-31 | 54.8M | — | Open → |
Shares outstanding — Shares outstanding is the number of shares in issue at the reporting date. A falling count usually means the company is buying back stock; a rising one means it is issuing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +2.0%
Shares outstanding at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Sinovac Biotech shares outstanding |url=https://companiesranked.com/en/company/sinovac-biotech/shares-outstanding |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Sinovac Biotech shares outstanding. CompaniesRanked. https://companiesranked.com/en/company/sinovac-biotech/shares-outstandingBibTeX
@misc{companiesranked-en-company-sinovac-biotech-shares-outstanding-2026,
author = {{CompaniesRanked}},
title = {{Sinovac Biotech shares outstanding}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/sinovac-biotech/shares-outstanding}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001193125-26-258534 · June 5, 2026
{{cite web |title=Sinovac Biotech shares outstanding — 20-F (0001193125-26-258534) |url=https://www.sec.gov/Archives/edgar/data/1084201/000119312526258534/sva-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-06-05}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.